| Authors: |
Siu DHW; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia.; Department of Medical Oncology, Illawarra Cancer Care Centre, Wollongong, NSW, Australia., Lin FPY; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia.; School of Clinical Medicine, University of New South Wales, Sydney, Australia., Thomas DM; Centre for Molecular Oncology, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia., Thavaneswaran S; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia.; School of Clinical Medicine, University of New South Wales, Sydney, Australia.; The Kinghorn Cancer Centre, St Vincent's Hospital, Sydney, Australia., Espinoza D; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia., Chinchen S; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia., Ballinger ML; Centre for Molecular Oncology, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia., Simes RJ; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia., Lee CK; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia.; Cancer Care Centre, St George Hospital, Kogarah, NSW, Australia. |
